UPDATE : Wednesday, June 19, 2019
Pangen wins Malaysia’s nod for epoetin alfa biosimilar
Pangen said Thursday that Malaysia’s National Pharmaceutical Regulatory Age...
by Lee Han-soo  |  2019-02-08 16:13
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea
Sanofi is preparing to seek an additional indication of Praluent (alirocuma...
by Kim Yun-mi  |  2019-02-08 16:12
Multinationals prepare next-generation pneumococcal vaccines
Multinational pharmaceutical firms are gearing up to replace conventional p...
by Kim Yun-mi  |  2019-02-08 12:02
Kainos Medicine starts developing treatment for multiple system atrophy
Kainos Medicine said Friday that it would develop a treatment for multiple ...
by Lee Han-soo  |  2019-02-08 11:47
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’
Novartis said Thursday that Cosentyx (Ingredient: secukinumab), its interle...
by Lee Han-soo  |  2019-02-07 17:14
Seoul accepts Bayer’s request to reduce study subjects of cancer drug
The government has accepted Bayer’s request to reduce the number of review ...
by Lee Hye-seon  |  2019-02-07 16:06
FDA starts inspecting SK Biopharm’s epilepsy treatment
SK Biopharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Lee Han-soo  |  2019-02-07 16:01
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment
Mediforum has signed a contract research agency contract with LSK Global PS...
by Lee Han-soo  |  2019-02-07 14:40
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales
MSD’s cancer immunotherapy Keytruda (ingredient: pembrolizumab) beat Bristo...
by Kim Yun-mi  |  2019-02-07 14:40
FDA OKs Daewoong’s BTX
Daewoong Pharmaceutical said that it received approval from the U.S. Food a...
by Lee Han-soo  |  2019-02-07 11:09
Pfizer feeling bittersweet over Korea’s biosimilars
Pfizer has lately seen both positive and negative impacts of Korean biosimi...
by Lee Han-soo  |  2019-02-01 17:04
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease
Novartis Korea’s dementia treatment Exelon (rivastigmine) obtained expanded...
by Kim Yun-mi  |  2019-02-01 17:02
‘Alunbrig works better for ALK-positive non-small cell lung cancer’
Second-line treatment options are increasing for patients with anaplastic l...
by Kim Yun-mi  |  2019-02-01 15:38
Medytox, Daewoong continue to squabble over BTX
A heated debate is continuing between Medytox and Daewoong Pharmaceuticals ...
by Lee Han-soo  |  2019-02-01 15:36
Santen Pharma to sell Huonland’s eye drop in China
Huonland said Wednesday that it has signed a memorandum of understanding wi...
by Lee Han-soo  |  2019-02-01 11:56
14 pharmaceuticals to release gastritis generic drugs soon
Fourteen pharmaceutical firms are to roll out generic copies of Stillen 2X ...
by Lee Hye-seon  |  2019-02-01 11:55
AbClon transfers target antibody technology to GC Labcell
GC Labcell said Wednesday that it has signed a 3 billion won ($2.7 million)...
by Lee Han-soo  |  2019-01-31 16:23
Novo Nordisk’s growth hormone injection gets expanded coverage
Novo Nordisk said Wednesday that the Ministry of Health and Welfare would e...
by Lee Han-soo  |  2019-01-31 15:18
‘Pseudoephedrine-containing drugs could cause acute skin reaction’ 
The government is likely to add a warning in the instructions of pseudoephe...
by Lee Hye-seon  |  2019-01-31 14:34
Kwangdong dismisses rumors of terminating sales for Contrav
Kwangdong Pharmaceutical denied Thursday rumors of the company stopping sal...
by Lee Han-soo  |  2019-01-31 14:32
Back to Top